On the evening of December 3, 2021, the "Kick-off Meeting of the Clinical Research Project of Polysaccharide Capsule for the Treatment of Chronic Hepatitis B Low-level Viremia" was held, and the meeting was held in the form of a combination of online and offline.
Professor Li Xiuhui from Beijing You'an Hospital Affiliated to Capital Medical University, together with Professor Jin Hua and relevant personnel from the participating units---- Professor Wang Xianbo from Beijing Ditan Hospital affiliated to Capital Medical University, Professor Zheng Haojie from Shijiazhuang Fifth Hospital, Professor Yang Yida and Professor Hao Shaorui from the First Affiliated Hospital of Zhejiang University School of Medicine attended and participated in the meeting. Mr. Zhang Min, Chairman of Hubei Mengyang Pharmaceutical Co., Ltd., the sponsor of the project, Ms. Huang Qian, Vice President of R&D, and Mr. Hu Kaiyong, R&D Director, all attended the meeting. The meeting was presided over by Mr. Li Yulong, Marketing Director of Beijing Kangzhong Times Medical Research and Development Co., Ltd.
Product traceability
Zhu Ling polysaccharide capsule (Guoyao Zhun Zi Z20184032) is a traditional Chinese medicine variety exclusively produced by Hubei Mengyang Pharmaceutical Co., Ltd., and is a variety of the new national medical insurance catalog (2021 version of the medical insurance catalog Chinese patent medicine part number 151). Zhu Ling polysaccharide capsule is famous - China Academy of Chinese Medical Sciences: In that year, Professor Tu Youyou of the China Academy of Chinese Medical Sciences participated in the research project of anti-malaria drugs (code 523), developed artemisinin, and won the Nobel Prize in 2015; Professor Zhang Ronglie of the China Academy of Chinese Medical Sciences is responsible for the research project of Polysaccharides (code 757), which discovered the role of Polysaccharides in the treatment of viral hepatitis and hepatoprotection. Previous clinical studies have reported that the treatment of chronic hepatitis B with or in combination with other western medicines can effectively inhibit the replication of hepatitis B virus, protect the liver and lower enzymes, and significantly improve clinical symptoms such as nausea, anorexia, abdominal distension, liver pain, etc., and there is no side effect in the application, which is worthy of clinical promotion and use. It has been included in the "Guidelines for the Diagnosis and Treatment of Chronic Hepatitis B in Traditional Chinese Medicine" and the "Expert Consensus on the Diagnosis and Treatment of Chronic Hepatitis B in Traditional Chinese Medicine", and has been rated as "the most competitive new variety of digestive drugs in the market".
Authentic medicinal herbs
As a commonly used mushroom medicinal material in China, Zhu Ling has a medicinal history of more than 2,000 years and enjoys a good reputation at home and abroad. The raw materials of Zhu Ling polysaccharide capsules are all made of authentic medicinal materials, Ningshan is the provincial area and geographical indication of Zhu Ling, and Mengyang Pharmaceutical has a high-quality provenance base Authentic medicinal herbs in Ningshan
As a commonly used mushroom medicinal material in China, Zhu Ling has a medicinal history of more than 2,000 years and enjoys a good reputation at home and abroad. Ningshan is the provincial area and geographical indication of Zhuling, Mengyang Pharmaceutical has a high-quality provenance base and industrialization demonstration base in Ningshan, in order to ensure the effectiveness and stability of the product.
set up a project
In order to further understand the characteristics of the clinical treatment of chronic hepatitis B, evaluate the heterogeneity of the clinical effect of Zhuling polysaccharide capsules, provide evidence-based medical evidence to verify the efficacy of the product and the safe and rational use of drugs, and meet the needs of the future academic development of the product, Mengyang Pharmaceutical has carried out standardized and systemat
